| CANDRIAM EQUITIES L BIOTECHNOLOGY I-H CAP EUR | RVI BIOTECNOLOGÍA | 3.231,540000 | 30/07/2026 | 16,33% | 69,68% | *** |
| BRANDES EMERGING MARKETS VALUE FUND A USD CAP | RVI EMERGENTES VALOR | 16,643430 | 30/07/2026 | 21,32% | 69,67% | **** |
| UBS (LUX) KEY SELECTION SICAV - EUROPEAN EQUITY VALUE OPPORTUNITY (EUR) Q-ACC | RVI EUROPA CRECIMIENTO | 289,700000 | 30/07/2026 | 18,85% | 69,67% | ***** |
| PRIVILEDGE - FIDELITY TECHNOLOGY (USD) I CAP | RVI TECNOLOGÍA | 140,325747 | 29/07/2026 | 11,36% | 69,66% | ** |
| POLAR CAPITAL JAPAN VALUE I GBP DIS | RVI JAPÓN VALOR | 1,892901 | 30/07/2026 | 21,82% | 69,64% | ** |
| MFS MERIDIAN CONTRARIAN VALUE FUND W1-GBP | RVI GLOBAL VALOR | 33,261389 | 30/07/2026 | 22,15% | 69,60% | ***** |
| SCHRODER ISF FRONTIER MARKETS EQUITY C ACC GBP | RVI EMERGENTES | 419,251590 | 30/07/2026 | 13,08% | 69,59% | *** |
| FIDELITY FUNDS-JAPAN GROWTH Y-ACC-EUR (HEDGED) | RVI JAPÓN | 42,540000 | 30/07/2026 | 17,61% | 69,55% | **** |
| GOLDMAN SACHS EUROPE CORE EQUITY PORTFOLIO I CHF CAP | RVI EUROPA | 19,272844 | 30/07/2026 | 13,90% | 69,55% | ***** |
| INVESCO EQQQ NASDAQ-100 UCITS ETF EUR HEDGED ACC | RVI USA | 482,572000 | 30/07/2026 | 9,59% | 69,55% | ***** |
